Discontinuation report NALOXONE HYDROCHLORIDE INJECTION
Report ID | 19858 |
Drug Identification Number | 02393034 |
Brand name | NALOXONE HYDROCHLORIDE INJECTION |
Common or Proper name | Naloxone Hydrochloride Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 1mL vial |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2017-08-18 |
Actual discontinuation date | 2017-08-18 |
Remaining supply date | 2017-08-18 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Replaced by DIN number 02455935 (Ethical) |
Company comments | Replaced by DIN number 02455935 (Ethical) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-08-18 | English | Compare |
v2 | 2017-08-18 | English | Compare |
v3 | 2017-08-18 | English | Compare |
v4 | 2017-08-18 | French | Compare |
v5 | 2017-08-19 | English | Compare |
Showing 1 to 5 of 5